Seizure Induced by Extended-Release Bupropion Used for Smoking Cessation at Early Term and Therapeutic Dose
PDF
Cite
Share
Request
Case Report
VOLUME: 24 ISSUE: 3
P: 127 - 129
December 2018

Seizure Induced by Extended-Release Bupropion Used for Smoking Cessation at Early Term and Therapeutic Dose

Arch Epilepsy 2018;24(3):127-129
1. Department of Neurology, Sakarya University Training and Research Hospital, Adapazarı, Turkey
2. Department of Neurology, Namık Kemal University Faculty of Medicine, Tekirdağ, Turkey
No information available.
No information available
Received Date: 06.10.2017
Accepted Date: 13.03.2018
PDF
Cite
Share
Request

ABSTRACT

Bupropion inhibits reuptakes of dopamine and noradrenaline. Since it is also a nicotine receptor antagonist, it acts as a drug used for smoking cessation. Bupropion is commonly preferred because of no side effects on weight, sexual function, and the lack of sedative effect. Immediate and sustained-release bupropion forms may trigger seizure activity. In the present article, we report a case of a 30-year-old man presenting with generalized tonic clonic seizures induced by extended-release bupropion. We also emphasized that extended-release bupropion, which is commonly used for smoking cessation therapy, may cause seizure at early term and therapeutic dose.

Keywords:
Extended-release bupropion, seizure, smoking cessation treatment